Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-14

Clinical Trial Update: Comparing Rezum and Urolift [NA]

View source ↗

Summary

A clinical trial sponsored by the Chinese University of Hong Kong comparing Rezum and UroLift is currently recruiting for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rezum Water Vapor Therapy
  • UroLift System

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Prostate Cancer | NA | Status: RECRUITING